rs554408082
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6_ModerateBS1BS2
The NM_007217.4(PDCD10):c.-284C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000952 in 152,350 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00095 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
PDCD10
NM_007217.4 5_prime_UTR
NM_007217.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.649
Publications
0 publications found
Genes affected
PDCD10 (HGNC:8761): (programmed cell death 10) This gene encodes an evolutionarily conserved protein associated with cell apoptosis. The protein interacts with the serine/threonine protein kinase MST4 to modulate the extracellular signal-regulated kinase (ERK) pathway. It also interacts with and is phosphoryated by serine/threonine kinase 25, and is thought to function in a signaling pathway essential for vascular developent. Mutations in this gene are one cause of cerebral cavernous malformations, which are vascular malformations that cause seizures and cerebral hemorrhages. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]
PDCD10 Gene-Disease associations (from GenCC):
- cerebral cavernous malformation 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- famililal cerebral cavernous malformationsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.22).
BP6
Variant 3-167734692-G-A is Benign according to our data. Variant chr3-167734692-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 590667.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000952 (145/152350) while in subpopulation NFE AF = 0.00175 (119/68038). AF 95% confidence interval is 0.00149. There are 0 homozygotes in GnomAd4. There are 68 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 145 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000952 AC: 145AN: 152232Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
145
AN:
152232
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 2198Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 1642
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
2198
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
1642
African (AFR)
AF:
AC:
0
AN:
20
American (AMR)
AF:
AC:
0
AN:
20
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
10
East Asian (EAS)
AF:
AC:
0
AN:
68
South Asian (SAS)
AF:
AC:
0
AN:
38
European-Finnish (FIN)
AF:
AC:
0
AN:
388
Middle Eastern (MID)
AF:
AC:
0
AN:
10
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1576
Other (OTH)
AF:
AC:
0
AN:
68
GnomAD4 genome AF: 0.000952 AC: 145AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.000913 AC XY: 68AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
145
AN:
152350
Hom.:
Cov.:
32
AF XY:
AC XY:
68
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
18
AN:
41586
American (AMR)
AF:
AC:
6
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5176
South Asian (SAS)
AF:
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
AC:
2
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
119
AN:
68038
Other (OTH)
AF:
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Apr 11, 2018
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.